Renal replacement therapy
- PMID: 40562857
- PMCID: PMC12317905
- DOI: 10.1007/s00134-025-07987-x
Renal replacement therapy
Conflict of interest statement
Declarations: Not applicable. Conflicts of interest: SG declares no competing interest regarding the submitted manuscript. NS has received honoraria or research support from Vantive Healthcare Corp, and Novartis outside the submitted work. MJ has received honoraria or research support from Baxter Healthcare Corp, AM-Pharma, CLS Behring, Fresenius, Takeda, and Novartis outside the submitted work.
Figures
References
-
- Gaudry S, Hajage D, Schortgen F et al (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375:122–133. 10.1056/NEJMoa1603017 - PubMed
-
- Barbar SD, Clere-Jehl R, Bourredjem A et al (2018) Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 379:1431–1442. 10.1056/NEJMoa1803213 - PubMed
-
- Bagshaw S, Wald R, Adhikari N et al (2020) Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med 383:240–251. 10.1056/NEJMoa2000741 - PubMed
-
- Gaudry S, Hajage D, Martin-Lefevre L et al (2021) Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet Lond Engl 397:1293–1300. 10.1016/S0140-6736(21)00350-0 - PubMed
-
- Vinsonneau C, Camus C, Combes A et al (2006) Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet Lond Engl 368:379–385. 10.1016/S0140-6736(06)69111-3 - PubMed
LinkOut - more resources
Full Text Sources
